"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente-San Francisco conducted 146 clinical trials. In the 10-year time frame, 146 clinical trials started and 128 clinical trials were completed, i.e. on average, 87.7% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 56 clinical trials were completed. i.e. 151.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-San Francisco" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 45 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "Gilead Sciences" with 16 trials sponsored and "Hoffmann-La Roche" with 16 trials sponsored. Other sponsors include 181 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-San Francisco" #1 collaborator was "National Cancer Institute (NCI)" with 124 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 150 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-San Francisco" are "HIV Infections" (38 trials), "Breast Cancer" (24 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Kaiser Permanente-San Francisco" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-San Francisco" are "Drug" (264 trials), "Other" (123 trials), "Biological" (82 trials), "Procedure" (49 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (47 trials), "Placebo" (29 trials), "Questionnaire Administration" (29 trials) and "Carboplatin" (27 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-San Francisco" are 287 trials for "All" genders, 59 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-San Francisco". undefined are not yet recruiting, 54 are recruiting, 100 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 169 completed trials in Kaiser Permanente-San Francisco, 4 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-San Francisco, 11 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 185 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 46 trials that are defined as “Not Applicable".